Abstracts from 2014 through the most recent CROI can be viewed in this searchable database once they have been presented at the conference. Abstract Contents: The searchable database includes abstract text as submitted by the authors prior to CROI. Study data might be updated during the presentation at CROI. Please refer to the electronic poster or webcast for updates. Searching the Abstract Database: Enter the criteria below and click the “Search” button. After the search has been entered, the results will appear below the search form.
CROI conference materials (eg, the conference program, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Permission to replicate or reproduce these elements, in whole or in part, must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data (including figures within abstracts or electronic posters) are the property of the study authors. Permission to use data and figures cannot be given by IAS–USA unless it is for regulatory reasons. For more information, please email CROIabstracts@iasusa.org.
1277 Results
A pharmacokinetic (PK) target is a specific drug concentration range in the body that ensures maximum efficacy while minimizing toxicity. In HIV clinical trials, selecting the correct PK target is crucial for the success of the study and the interpretation of its results. This issue is particularly relevant when evaluating the treatment of understudied…
The genetic material of HIV-1 is packaged inside a cone shaped container that is called the viral core. To infect a cell, the viral core must pass through the cell’s nuclear pore. Using atomic force microscopy, a technique that uses a tiny needle to feel the surface of things at the microscopic level, and molecular…
We use the power of CRISPR-based gene editing technologies to decode and rewrite DNA programs that govern cells in the human immune system. Human immune cells, especially T cells, can be genetically engineered to target various cancers. Despite their utility for the treatment of hematological malignancies, chimeric antigen receptor (CAR) T cells have significant limitations,…
$$$Add presentation summary.$$$
Most liver cancer (also called hepatocellular cancer, or HCC) cases occur in patients with established risk factors for chronic liver disease, including hepatitis C virus (HCV) infection, heavy alcohol drinking, hepatitis B virus (HBV) infection, and metabolic dysfunction associated steatotic liver disease (MASLD). These HCC risk factors lead to cirrhosis, which is present in 90%…
In this session, Drs. Pedro Cahn and Jenny Hoy will present cases to an expert faculty panel from around the world to highlight cutting-edge issues in the care of people with HIV. Topics will include the management of weight gain in the setting of ART, the approach to cardiovascular events in people with HIV, whether…
Over the past four decades, remarkable progress has been made in understanding HIV epidemiology, pathogenesis, treatment, and prevention from the combined efforts of community members, clinicians, investigators, and funding agencies worldwide. Yet more work and new approaches are needed to achieve the ambitious goal of ending the epidemic and ensuring optimal quality of life for…
In the past 12 years, 6.2 million individuals globally have been prescribed PrEP since its initial approval by the US FDA. The majority of these prescriptions, 1.4 million, have been issued in the past two years. However, oral PrEP’s effectiveness is contingent on high adherence, posing challenges for certain high-risk groups. Research indicates that long-acting…
$$$ Add presentation summary. $$$
In Mexico, stigma and inequality limit access to HIV prevention tools like PrEP and PEP. Alain Pinzón of VIHve Libre has developed a peer-based, technology-supported program to overcome these barriers. Participants connect via social media, enroll through a digital platform, and access testing and medication either in person or via courier services. Personalized counseling ensures…